Dading, Latip .
HRN: 23-56-06 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2024
CEFTAZIDIME 1GM (VIAL)
01/04/2024
01/10/2024
IV
1g
Q12
Nonhealing Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueEye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes